{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,7]],"date-time":"2026-11-07T02:51:52Z","timestamp":1794019912770,"version":"4.8.0"},"reference-count":44,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2023,2,21]],"date-time":"2023-02-21T00:00:00Z","timestamp":1676937600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2023,2,21]],"date-time":"2023-02-21T00:00:00Z","timestamp":1676937600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"DOI":"10.13039\/501100002347","name":"Bundesministerium f\u00fcr Bildung und Forschung","doi-asserted-by":"publisher","award":["F01KI1909A"],"award-info":[{"award-number":["F01KI1909A"]}],"id":[{"id":"10.13039\/501100002347","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100002347","name":"Bundesministerium f\u00fcr Bildung und Forschung","doi-asserted-by":"publisher","award":["F01KI1909A"],"award-info":[{"award-number":["F01KI1909A"]}],"id":[{"id":"10.13039\/501100002347","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100011022","name":"Vertex Pharmaceuticals","doi-asserted-by":"publisher","award":["Circle of Care"],"award-info":[{"award-number":["Circle of Care"]}],"id":[{"id":"10.13039\/100011022","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100014584","name":"Universit\u00e4tsmedizin der Johannes Gutenberg-Universit\u00e4t Mainz","doi-asserted-by":"crossref","id":[{"id":"10.13039\/501100014584","id-type":"DOI","asserted-by":"crossref"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["BMC Microbiol"],"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:sec>\n                    <jats:title>Background<\/jats:title>\n                    <jats:p>Impaired respiratory and intestinal microbiome composition is linked to cystic fibrosis lung disease severity. In people with cystic fibrosis (pwCF), regular exercise is recommended to delay disease progression and preserve a stable lung function. An optimal nutritional status is vital for best clinical outcomes. Our study investigated whether regular and monitored exercise and nutritional support promotes CF microbiome health.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods<\/jats:title>\n                    <jats:p>\n                      A personalized nutrition and exercise program promoted nutritional intake and physical fitness in 18 pwCF for 12\u00a0months. Throughout the study, patients performed strength and endurance training monitored by a sports scientist via an internet platform. After three months, food supplementation with\n                      <jats:italic>Lactobacillus rhamnosus<\/jats:italic>\n                      LGG was introduced. Nutritional status and physical fitness were assessed before the study started, after three and nine months. Sputum and stool were collected, and microbial composition was analyzed by 16S rRNA gene sequencing.\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>Sputum and stool microbiome composition remained stable and highly specific to each patient during the study period. Disease-associated pathogens dominated sputum composition. Lung disease severity and recent antibiotic treatment had the highest impact on taxonomic composition in stool and sputum microbiome. Strikingly, the long-term antibiotic treatment burden had only a minor influence.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusion<\/jats:title>\n                    <jats:p>Despite the exercise and nutritional intervention, respiratory and intestinal microbiomes proved to be resilient. Dominant pathogens drove the composition and functionality of the microbiome. Further studies are required to understand which therapy could destabilize the dominant disease-associated microbial composition of pwCF.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1186\/s12866-023-02788-y","type":"journal-article","created":{"date-parts":[[2023,2,21]],"date-time":"2023-02-21T02:05:27Z","timestamp":1676945127000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":10,"title":["Resilience and stability of the CF- intestinal and\u00a0respiratory microbiome during nutritional and exercise intervention"],"prefix":"10.1186","volume":"23","author":[{"given":"Rebecca L.","family":"Knoll","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"V\u00edctor Hugo","family":"Jarqu\u00edn-D\u00edaz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jonas","family":"Klopp","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alissa","family":"Kemper","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Katja","family":"Hilbert","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Barlo","family":"Hillen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Daniel","family":"Pfirrmann","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Perikles","family":"Simon","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Viola","family":"B\u00e4hner","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Oliver","family":"Nitsche","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Stephan","family":"Gehring","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lajos","family":"Mark\u00f3","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sofia K.","family":"Forslund","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Krystyna","family":"Poplawska","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2023,2,21]]},"reference":[{"issue":"10059","key":"2788_CR1","doi-asserted-by":"publisher","first-page":"2519","DOI":"10.1016\/S0140-6736(16)00576-6","volume":"388","author":"JS Elborn","year":"2016","unstructured":"Elborn JS. Cystic fibrosis. Lancet. 2016;388(10059):2519\u201331.","journal-title":"Lancet"},{"key":"2788_CR2","doi-asserted-by":"publisher","unstructured":"Rogers G, Huang YJ. Chronic suppurative lung disease: cystic fibrosis and non-cystic fibrosis bronchiectasis. In: Cox MJ, Ege MJ, von Mutius E, eds. The Lung Microbiome (ERS Monograph). Sheffield, European Respiratory Society, 2019; pp. 158\u2013172 [https:\/\/doi.org\/10.1183\/2312508X.10016218].","DOI":"10.1183\/2312508X.10016218"},{"issue":"4","key":"2788_CR3","doi-asserted-by":"publisher","first-page":"553","DOI":"10.1016\/j.jcf.2020.04.007","volume":"19","author":"M Kristensen","year":"2020","unstructured":"Kristensen M, Prevaes SMPJ, Kalkman G, Tramper-Stranders GA, Hasrat R, de Winter-de Groot KM, et al. Development of the gut microbiota in early life: The impact of cystic fibrosis and antibiotic treatment. J Cyst Fibros. 2020;19(4):553\u201361.","journal-title":"J Cyst Fibros"},{"issue":"6","key":"2788_CR4","doi-asserted-by":"publisher","first-page":"e04104","DOI":"10.1016\/j.heliyon.2020.e04104","volume":"6","author":"A Hahn","year":"2020","unstructured":"Hahn A, Burrell A, Ansusinha E, Peng D, Chaney H, Sami I, et al. Airway microbial diversity is decreased in young children with cystic fibrosis compared to healthy controls but improved with CFTR modulation. Heliyon. 2020;6(6):e04104. https:\/\/doi.org\/10.1016\/j.heliyon.2020.e04104.","journal-title":"Heliyon"},{"issue":"1","key":"2788_CR5","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1371\/journal.ppat.1006798","volume":"14","author":"MS Muhlebach","year":"2018","unstructured":"Muhlebach MS, Zorn BT, Esther CR, Hatch JE, Murray CP, Turkovic L, et al. Initial acquisition and succession of the cystic fibrosis lung microbiome is associated with disease progression in infants and preschool children. PLoS Pathog. 2018;14(1):1\u201320.","journal-title":"PLoS Pathog"},{"key":"2788_CR6","doi-asserted-by":"crossref","unstructured":"Nielsen S, Needham B, Leach ST, Day AS, Jaffe A, Thomas T, et al. Disrupted progression of the intestinal microbiota with age in children with cystic fibrosis. 2016;6(1):24857. Available from: www.nature.com\/scientificreports.[cited 2018 Jul 24]","DOI":"10.1038\/srep24857"},{"issue":"16","key":"2788_CR7","doi-asserted-by":"publisher","first-page":"e00274","DOI":"10.1128\/JB.00274-19","volume":"201","author":"KM Antosca","year":"2019","unstructured":"Antosca KM, Chernikova DA, Price CE, Ruoff KL, Li K, Guill MF, et al. Altered stool microbiota of infants with cystic fibrosis shows a reduction in genera associated with immune programming from birth. J Bacteriol. 2019;201(16):e00274-19.","journal-title":"J Bacteriol."},{"key":"2788_CR8","doi-asserted-by":"publisher","unstructured":"Vernocchi P, del Chierico F, Russo A, Majo F, Rossitto M, Valerio M, et al. Gut microbiota signatures in cystic fibrosis: Loss of host CFTR function drives the microbiota enterophenotype. 2018. https:\/\/doi.org\/10.1371\/journal.pone.0208171","DOI":"10.1371\/journal.pone.0208171"},{"issue":"2","key":"2788_CR9","doi-asserted-by":"publisher","first-page":"1","DOI":"10.3390\/metabo11020123","volume":"11","author":"A Thavamani","year":"2021","unstructured":"Thavamani A, Salem I, Sferra TJ, Sankararaman S. Impact of altered gut microbiota and its metabolites in cystic fibrosis. Metabolites. 2021;11(2):1\u201322.","journal-title":"Metabolites"},{"issue":"4","key":"2788_CR10","doi-asserted-by":"publisher","first-page":"740","DOI":"10.1016\/j.clinthera.2016.02.008","volume":"38","author":"JC Madan","year":"2016","unstructured":"Madan JC. Neonatal gastrointestinal and respiratory Microbiome in cystic fibrosis: potential interactions and implications for systemic health. Clin Ther. 2016;38(4):740\u20136. https:\/\/doi.org\/10.1016\/j.clinthera.2016.02.008.","journal-title":"Clin Ther"},{"issue":"1","key":"2788_CR11","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/s40168-020-00810-3","volume":"8","author":"L Cuthbertson","year":"2020","unstructured":"Cuthbertson L, Walker AW, Oliver AE, Rogers GB, Rivett DW, Hampton TH, et al. Lung function and microbiota diversity in cystic fibrosis. Microbiome. 2020;8(1):1\u201313.","journal-title":"Microbiome"},{"issue":"1","key":"2788_CR12","doi-asserted-by":"publisher","first-page":"13","DOI":"10.1016\/j.jcf.2018.11.003","volume":"18","author":"G H\u00e9ry-Arnaud","year":"2019","unstructured":"H\u00e9ry-Arnaud G, Boutin S, Cuthbertson L, Elborn SJ, Tunney MM. The lung and gut microbiome: what has to be taken into consideration for cystic fibrosis? J Cyst Fibros. 2019;18(1):13\u201321. https:\/\/doi.org\/10.1016\/j.jcf.2018.11.003.","journal-title":"J Cyst Fibros"},{"key":"2788_CR13","first-page":"e0031121","volume":"203","author":"CE Price","year":"2021","unstructured":"Price CE, O\u2019Toole GA. The gut-lung axis in cystic Fibrosis. J Bacteriol Am Soc Microbiol. 2021;203:e0031121.","journal-title":"J Bacteriol Am Soc Microbiol."},{"key":"2788_CR14","doi-asserted-by":"crossref","unstructured":"Wu GD, Chen J, Hoffmann C, Bittinger K, Chen YY, Keilbaugh SA, et al. Linking long-term dietary patterns with gut microbial enterotypes. Science (1979). 2011\/09\/03. 2011;334(6052):105\u20138. Available from: http:\/\/www.ncbi.nlm.nih.gov\/pmc\/articles\/PMC3368382\/pdf\/nihms378475.pdf","DOI":"10.1126\/science.1208344"},{"issue":"7484","key":"2788_CR15","doi-asserted-by":"publisher","first-page":"559","DOI":"10.1038\/nature12820","volume":"505","author":"LA David","year":"2014","unstructured":"David LA, Maurice CF, Carmody RN, Gootenberg DB, Button JE, Wolfe BE, et al. Diet rapidly and reproducibly alters the human gut microbiome. Nature. 2014;505(7484):559\u201363. https:\/\/doi.org\/10.1038\/nature12820.","journal-title":"Nature."},{"issue":"16","key":"2788_CR16","doi-asserted-by":"publisher","first-page":"4137","DOI":"10.1016\/j.cell.2021.06.019","volume":"184","author":"HC Wastyk","year":"2021","unstructured":"Wastyk HC, Fragiadakis GK, Perelman D, Dahan D, Merrill BD, Yu FB, et al. Gut-microbiota-targeted diets modulate human immune status. Cell. 2021;184(16):4137-4153.e14. https:\/\/doi.org\/10.1016\/j.cell.2021.06.019.","journal-title":"Cell."},{"issue":"1","key":"2788_CR17","doi-asserted-by":"publisher","first-page":"81","DOI":"10.1097\/MPG.0000000000000187","volume":"58","author":"G di Nardo","year":"2014","unstructured":"di Nardo G, Oliva S, Menichella A, Pistelli R, de Biase RV, Patriarchi F, et al. Lactobacillus reuteri ATCC55730 in cystic fibrosis. J Pediatr Gastroenterol Nutr. 2014;58(1):81\u20136.","journal-title":"J Pediatr Gastroenterol Nutr"},{"key":"2788_CR18","unstructured":"Bruzzese E, Callegari ML, Raia V, Viscovo S, Scotto R, Ferrari S, et al. Disrupted Intestinal Microbiota and Intestinal Inflammation in Children with Cystic Fibrosis and Its Restoration with Lactobacillus GG: A Randomised Clinical Trial. Available from: www.plosone.org"},{"issue":"2","key":"2788_CR19","doi-asserted-by":"publisher","first-page":"186","DOI":"10.1016\/j.jcf.2016.09.004","volume":"16","author":"JL Anderson","year":"2017","unstructured":"Anderson JL, Miles C, Tierney AC. Effect of probiotics on respiratory, gastrointestinal and nutritional outcomes in patients with cystic fibrosis: A systematic review. J Cyst Fibros. 2017;16(2):186\u201397. https:\/\/doi.org\/10.1016\/j.jcf.2016.09.004.","journal-title":"J Cyst Fibros"},{"key":"2788_CR20","doi-asserted-by":"publisher","first-page":"637010","DOI":"10.3389\/fnut.2021.637010","volume":"8","author":"M Clauss","year":"2021","unstructured":"Clauss M, G\u00e9rard P, Mosca A, Leclerc M. Interplay Between Exercise and Gut Microbiome in the Context of Human Health and Performance. Front Nutr. 2021;8:637010.\u00a0Available from:\u00a0www.frontiersin.org","journal-title":"Front Nutr"},{"issue":"10","key":"2788_CR21","doi-asserted-by":"publisher","first-page":"1","DOI":"10.3390\/nu12102936","volume":"12","author":"M Marttinen","year":"2020","unstructured":"Marttinen M, Ala-Jaakkola R, Laitila A, Lehtinen MJ. Gut microbiota, probiotics and physical performance in athletes and physically active individuals. Nutrients. 2020;12(10):1\u201339.","journal-title":"Nutrients"},{"issue":"1","key":"2788_CR22","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/s13102-021-00323-y","volume":"13","author":"B Hillen","year":"2021","unstructured":"Hillen B, Simon P, Schlotter S, Nitsche O, B\u00e4hner V, Poplawska K, et al. Feasibility and implementation of a personalized, web-based exercise intervention for people with cystic fibrosis for 1 year. BMC Sports Sci Med Rehabil. 2021;13(1):1\u201311. https:\/\/doi.org\/10.1186\/s13102-021-00323-y.","journal-title":"BMC Sports Sci Med Rehabil"},{"issue":"3","key":"2788_CR23","doi-asserted-by":"publisher","first-page":"557","DOI":"10.1016\/j.clnu.2016.03.004","volume":"35","author":"D Turck","year":"2016","unstructured":"Turck D, Braegger CP, Colombo C, Declercq D, Morton A, Pancheva R, et al. ESPEN-ESPGHAN-ECFS guidelines on nutrition care for infants, children, and adults with cystic fibrosis. Clin Nutr. 2016;35(3):557\u201377. https:\/\/doi.org\/10.1016\/j.clnu.2016.03.004.","journal-title":"Clin Nutr"},{"issue":"5","key":"2788_CR24","doi-asserted-by":"publisher","first-page":"754","DOI":"10.1016\/j.jcf.2020.12.022","volume":"20","author":"DL Frey","year":"2021","unstructured":"Frey DL, Boutin S, Dittrich SA, Graeber SY, Stahl M, Wege S, et al. Relationship between airway dysbiosis, inflammation and lung function in adults with cystic fibrosis. J Cyst Fibros. 2021;20(5):754\u201360.","journal-title":"J Cyst Fibros"},{"issue":"10","key":"2788_CR25","doi-asserted-by":"publisher","first-page":"630","DOI":"10.1038\/nrmicro.2017.58","volume":"15","author":"F Sommer","year":"2017","unstructured":"Sommer F, Anderson JM, Bharti R, Raes J, Rosenstiel P. The resilience of the intestinal microbiota influences health and disease. Nat Rev Microbiol. 2017;15(10):630\u20138. https:\/\/doi.org\/10.1038\/nrmicro.2017.58.","journal-title":"Nat Rev Microbiol"},{"issue":"1","key":"2788_CR26","doi-asserted-by":"publisher","first-page":"94","DOI":"10.1249\/MSS.0000000000002112","volume":"52","author":"KK Motiani","year":"2020","unstructured":"Motiani KK, Collado MC, Eskelinen JJ, Virtanen KA, L\u00f6yttyniemi E, Salminen S, et al. Exercise training modulates gut microbiota profile and improves endotoxemia. Med Sci Sports Exerc. 2020;52(1):94\u2013104.","journal-title":"Med Sci Sports Exerc"},{"issue":"1","key":"2788_CR27","doi-asserted-by":"publisher","first-page":"125","DOI":"10.1038\/s41366-019-0440-y","volume":"44","author":"T Kern","year":"2020","unstructured":"Kern T, Blond MB, Hansen TH, Rosenkilde M, Quist JS, Gram AS, et al. Structured exercise alters the gut microbiota in humans with overweight and obesity\u2014A randomized controlled trial. Int J Obes. 2020;44(1):125\u201335.","journal-title":"Int J Obes"},{"issue":"2","key":"2788_CR28","doi-asserted-by":"publisher","first-page":"181","DOI":"10.1017\/S0029665115004206","volume":"75","author":"MJ M\u00fcller","year":"2016","unstructured":"M\u00fcller MJ, Braun W, Pourhassan M, Geisler C, Bosy-Westphal A. Application of standards and models in body composition analysis. Proc Nutr Soc. 2016;75(2):181\u20137.","journal-title":"Proc Nutr Soc"},{"issue":"1","key":"2788_CR29","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/s12866-021-02214-1","volume":"21","author":"L Moitinho-Silva","year":"2021","unstructured":"Moitinho-Silva L, Wegener M, May S, Schrinner F, Akhtar A, Boysen TJ, et al. Short-term physical exercise impacts on the human holobiont obtained by a randomised intervention study. BMC Microbiol. 2021;21(1):1\u201314.","journal-title":"BMC Microbiol"},{"key":"2788_CR30","doi-asserted-by":"publisher","first-page":"363","DOI":"10.1016\/j.jad.2021.06.025","volume":"293","author":"R Wang","year":"2021","unstructured":"Wang R, Cai Y, Li J, Yau SY, Lu W, Stubbs B, et al. Effects of aerobic exercise on gut microbiota in adolescents with subthreshold mood syndromes and healthy adolescents: A 12-week, randomized controlled trial. J Affect Disord. 2021;293:363\u201372.","journal-title":"J Affect Disord"},{"issue":"4","key":"2788_CR31","doi-asserted-by":"publisher","first-page":"678","DOI":"10.1016\/j.jcf.2021.03.022","volume":"20","author":"SK Lucas","year":"2021","unstructured":"Lucas SK, Feddema E, Boyer HC, Hunter RC. Diversity of cystic fibrosis chronic rhinosinusitis microbiota correlates with different pathogen dominance. J Cyst Fibros. 2021;20(4):678\u201381. https:\/\/doi.org\/10.1016\/j.jcf.2021.03.022.","journal-title":"J Cyst Fibros"},{"key":"2788_CR32","unstructured":"Losada PM, Chouvarine P, Dorda M, Hedtfeld S, Mielke S, Schulz A, et al. The cystic fibrosis lower airways microbial metagenome. Available from: http:\/\/ow.ly\/ZiqUE"},{"issue":"5","key":"2788_CR33","doi-asserted-by":"publisher","first-page":"1081","DOI":"10.1038\/ismej.2015.198","volume":"10","author":"L Cuthbertson","year":"2016","unstructured":"Cuthbertson L, Rogers GB, Walker AW, Oliver A, Green LE, Daniels TWV, et al. Respiratory microbiota resistance and resilience to pulmonary exacerbation and subsequent antimicrobial intervention. ISME J. 2016;10(5):1081\u201391. https:\/\/doi.org\/10.1038\/ismej.2015.198.","journal-title":"ISME J"},{"issue":"9","key":"2788_CR34","doi-asserted-by":"publisher","first-page":"e45001","DOI":"10.1371\/journal.pone.0045001","volume":"7","author":"AA Fodor","year":"2012","unstructured":"Fodor AA, Klem ER, Gilpin DF, Elborn JS, Boucher RC, Tunney MM, et al. The Adult Cystic Fibrosis Airway Microbiota Is Stable over Time and Infection Type, and Highly Resilient to Antibiotic Treatment of Exacerbations. PLoS One. 2012;7(9):e45001.","journal-title":"PLoS One."},{"key":"2788_CR35","unstructured":"Nelson MT, Wolter DJ, Weiss EJ, Vo AT. Maintenance tobramycin primarily affects untargeted bacteria in the CF sputum microbiome. Available from: http:\/\/thorax.bmj.com\/"},{"issue":"12","key":"2788_CR36","doi-asserted-by":"publisher","first-page":"1110","DOI":"10.1016\/j.molmed.2019.07.008","volume":"25","author":"A Bevivino","year":"2019","unstructured":"Bevivino A, Bacci G, Drevinek P, Nelson MT, Hoffman L, Mengoni A. Deciphering the Ecology of Cystic Fibrosis Bacterial Communities: Towards Systems-Level Integration. Trends Mol Med. 2019;25(12):1110\u201322.","journal-title":"Trends Mol Med"},{"issue":"7889","key":"2788_CR37","doi-asserted-by":"publisher","first-page":"500","DOI":"10.1038\/s41586-021-04177-9","volume":"600","author":"SK Forslund","year":"2021","unstructured":"Forslund SK, Chakaroun R, Zimmermann-Kogadeeva M, Mark\u00f3 L, Aron-Wisnewsky J, Nielsen T, et al. Combinatorial, additive and dose-dependent drug\u2013microbiome associations. Nature. 2021;600(7889):500\u20135.","journal-title":"Nature"},{"issue":"1","key":"2788_CR38","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/s12866-016-0921-2","volume":"17","author":"DG Burke","year":"2017","unstructured":"Burke DG, Fouhy F, Harrison MJ, Rea MC, Cotter PD, O\u2019Sullivan O, et al. The altered gut microbiota in adults with cystic fibrosis. BMC Microbiol. 2017;17(1):1\u201311.","journal-title":"BMC Microbiol"},{"key":"2788_CR39","doi-asserted-by":"publisher","unstructured":"Marsh R, Gavillet H, Hanson L, Ng C, Mitchell-Whyte M, Major G, et al. Intestinal function and transit associate with gut microbiota dysbiosis in cystic fibrosis. J Cyst Fibros. 2021;(xxxx). https:\/\/doi.org\/10.1016\/j.jcf.2021.11.014","DOI":"10.1016\/j.jcf.2021.11.014"},{"key":"2788_CR40","doi-asserted-by":"publisher","first-page":"515","DOI":"10.1016\/j.chom.2016.09.001","volume":"20","author":"MX Maldonado-G\u00f3mez","year":"2016","unstructured":"Maldonado-G\u00f3mez MX, Mart\u00ednez I, Bottacini F, O\u2019Callaghan A, Ventura M, van Sinderen D, et al. Stable Engraftment of Bifidobacterium longum AH1206 in the Human Gut Depends on Individualized Features of the Resident Microbiome. Cell Host Microbe. 2016;20:515\u201326.","journal-title":"Cell Host Microbe."},{"issue":"6","key":"2788_CR41","doi-asserted-by":"publisher","first-page":"825","DOI":"10.1016\/j.jcf.2016.05.004","volume":"15","author":"AM Charatsi","year":"2016","unstructured":"Charatsi AM, Dusser P, Freund R, Maruani G, Rossin H, Boulier A, et al. Bioelectrical impedance in young patients with cystic fibrosis: Validation of a specific equation and clinical relevance. J Cyst Fibros. 2016;15(6):825\u201333.","journal-title":"J Cyst Fibros"},{"key":"2788_CR42","doi-asserted-by":"crossref","unstructured":"Knoll RL, Forslund K, Kultima JRJR, Meyer CU, Kullmer U, Sunagawa S, et al. Gut microbiota differs between children with Inflammatory Bowel Disease and healthy siblings in taxonomic and functional composition: a metagenomic analysis. Am J Physiol Gastrointest Liver Physiol. 2017;312(4):G327\u201339. Available from: http:\/\/ajpgi.physiology.org\/lookup\/doi\/https:\/\/doi.org\/10.1152\/ajpgi.00293.2016","DOI":"10.1152\/ajpgi.00293.2016"},{"issue":"9","key":"2788_CR43","doi-asserted-by":"publisher","first-page":"814","DOI":"10.1038\/nbt.2676","volume":"31","author":"MGI Langille","year":"2013","unstructured":"Langille MGI, Zaneveld J, Caporaso JG, McDonald D, Knights D, Reyes JA, et al. Predictive functional profiling of microbial communities using 16S rRNA marker gene sequences. Nat Biotechnol. 2013;31(9):814\u201321. https:\/\/doi.org\/10.1038\/nbt.2676.","journal-title":"Nat Biotechnol"},{"key":"2788_CR44","volume-title":"metadeconfoundR","author":"T Birkner","year":"2021","unstructured":"Birkner T. metadeconfoundR. 2021.\u00a0Available from:\u00a0https:\/\/github.com\/TillBirkner\/metadeconfoundR."}],"container-title":["BMC Microbiology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12866-023-02788-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12866-023-02788-y\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12866-023-02788-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,2,21]],"date-time":"2023-02-21T02:07:25Z","timestamp":1676945245000},"score":1,"resource":{"primary":{"URL":"https:\/\/bmcmicrobiol.biomedcentral.com\/articles\/10.1186\/s12866-023-02788-y"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,2,21]]},"references-count":44,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2023,12]]}},"alternative-id":["2788"],"URL":"https:\/\/doi.org\/10.1186\/s12866-023-02788-y","relation":{"has-preprint":[{"id-type":"doi","id":"10.21203\/rs.3.rs-1811474\/v1","asserted-by":"object"}]},"ISSN":["1471-2180"],"issn-type":[{"value":"1471-2180","type":"electronic"}],"subject":[],"published":{"date-parts":[[2023,2,21]]},"assertion":[{"value":"30 June 2022","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"17 October 2022","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"21 February 2023","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The study was performed in accordance with the Declaration of Helsinki and was approved by the ethics committee from the State Chamber of Physicians of Rhineland-Palatinate (RN 837.288.16 (10607)). Written informed consent was provided by all adult subjects, and parents or guardians of underaged participants provided written informed consent on their behalf along with written assent from the underaged participants.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"Krystyna Poplawska received personal payment for participation on the advisory board in December 2021 (Vertex Pharmaceuticals).  All other authors have no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"44"}}